← Feed

Sabag Mark

SEC Form 4 insider
See "Remarks" · TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA)
2 theses · first seen Nov 6, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$TEVASEC Form 4bearish
Sabag Mark · See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD · 20h ago1 prior · awaiting results
Sold 44,710 @ $44.14 avg · $1,973,544 · 2026-11-12

Form 4: Sabag Mark sold TEVA

Sabag Mark (See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD) reported an open-market sale of 44,710 shares of TEVA at an average $44.14, roughly $1,973,544, in a Form 4 filed 2026-11-12.

Now $43.65as of Nov 12, 4:31 PM ET
View filing on SEC.gov →
$TEVASEC Form 4bearish
Sabag Mark · See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD · 7d ago1 prior · awaiting results
Sold 46,000 @ $41.93 avg · $1,928,729 · 2026-11-05

Form 4: Sabag Mark sold TEVA

Sabag Mark (See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD) reported an open-market sale of 46,000 shares of TEVA at an average $41.93, roughly $1,928,729, in a Form 4 filed 2026-11-06.

Now $43.65as of Nov 12, 4:31 PM ET
View filing on SEC.gov →

End of results.